Histologic examination of prostate tissue. Surgical pathology level 4 (per individually identified specimen site), with microscopic interpretation and report.
PTEN (10q23.32) and TMPRss2-ERG (21q22.2) loci are assessed by fluorescent in situ hybridization (FISH) using three-color MetaSystems XCyting locus-specific probes. Aberrations of ERG (deletion, copy number increase, and rearrangement) have been reported in prostate cancer. Deletions of PTEN have been reported in prostate cancer.
Genoptix, a NeoGenomics Company
2131 Faraday Ave
Carlsbad, CA 92008
Medical Director: Derek Lyle, MD
- NeoGenomics Completes Acquisition of Genoptix, Inc.December 10, 2018 - 9:00 am
- NeoGenomics Signs Definitive Agreement to Acquire GenoptixOctober 23, 2018 - 9:00 am
- Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib)September 4, 2018 - 8:30 am
HOURS OF OPERATION
Our lab is open six days a week:
5:00am to 6:00pm PT Mon-Fri
7:00am to 3:30pm PT Saturday
For after-hours assistance, your call
will be connected with an on-duty
Client Services Representative.